Mindimmune Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Mindimmune Therapeutics

Access the complete profile.

Mindimmune Therapeutics Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	7 Greenhouse Rd Kingston, RI 02881

Note: Revenues for privately held companies are statistical evaluations.


Mindimmune Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Mindimmune Therapeutics's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Mindimmune Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Mindimmune Therapeutics Annual Revenue and Growth Rate

Mindimmune Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$1 - $10 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Mindimmune Therapeutics's revenues are gauged from an analysis of company filings.

Mindimmune Therapeutics's Income Statement (based on Industry Averages)

Mindimmune Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Mindimmune Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
February 4, 2022	12	60%	$9 MM
Complete list of funding rounds and total amounts in the Company Report

Market Share of Mindimmune Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Mindimmune Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Mindimmune Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
NEUROTECH USA	Cumberland, RI	100
VOLTSERVER	East Greenwich, RI	68
REGENT CRAFT	North Kingstown, RI	55
PRO-CHANGE BEHAVIOR SYSTEMS	Narragansett, RI	17
BTECH ACOUSTICS	Barrington, RI	16
MINDIMMUNE THERAPEUTICS	Kingston, RI	12

Future Competition: Mindimmune Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Mindimmune Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)